Gallant went above and beyond to ensure my pet's stem cells were collected and successfully banked! They made sure my vet had all the support and assistance he needed as a first time participant in the process. I would recommend Gallant to any pet parent looking to partner with an innovative company in securing the healthiest possible future for your pet.
Claim your business profile now and gain access to all features and respond to customer reviews.
Gallant is a clinical-stage animal health biotechnology company setting a new standard in animal health by harnessing the power of stem cell therapy to treat the root cause of diseases in dogs and cats. Our pipeline of off-the-shelf mesenchymal stem cell (MSC) therapies has the potential to treat a broad range of diseases, including canine and feline osteoarthritis (OA), feline chronic kidney disease (CKD), and others. The first product based on our uterine-derived platform for feline chronic gingivostomatitis (FCGS), is on track for conditional approval by the FDA in 2025. United by a love of and commitment to animals, Gallant’s team includes industry pioneers in veterinary regenerative medicine with deep experience in cell therapy product development, manufacturing, and commercialization.See more
